id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3872-0005,FDA,FDA-2024-E-3872,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-25T02:57:34Z,,0,0,09000064b9095140
FDA-2024-E-3872-0004,FDA,FDA-2024-E-3872,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,,2025-09-11T17:17:31Z,,0,0,09000064b8f528c0
FDA-2024-E-3872-0003,FDA,FDA-2024-E-3872,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-08-19T04:00:00Z,2025,8,2025-08-19T04:00:00Z,,2025-08-20T00:35:06Z,,0,0,09000064b8f07bb3